Publications by authors named "Abdalla Abdalla Mohamed"
Background: Following the World Health Organization declaration, COVID-19 was first appearance in Sudan was in March 2020. Cases were reported to the Sudan Federal Ministry of Heath through the surveillance system from different sources. This study used surveillance data from 2020 to 2021 to describe the epidemiologic patterns of COVID-19 occurrence in Sudan and provide insight for better preparedness and response.
View Article and Find Full Text PDFSafety and efficacy of daridorexant in the treatment of insomnia: a systematic review and meta-analysis of randomized controlled trials.
Muayad Saud Albadrani Muhannad Saud Albadrani Hammad Ali Fadlalmola Amal Mohamed Elhusein Randa Mohamed Abobaker Abdalla Mohamed Abdalla Adel Mohamed Ali Abdalla
Int Clin Psychopharmacol
January 2023
Daridorexant is a novel dual orexin receptor antagonist used in treating insomnia disorder. Daridorexant improves sleep quality without impairing daytime functioning. We assess the safety and efficacy of this novel drug in the treatment of insomnia.
View Article and Find Full Text PDFArticle Synopsis
- Cholecystectomy, particularly laparoscopic surgery, is commonly performed but not always available in developing countries; mini-laparotomy cholecystectomy is a safer alternative with a smaller incision.
- A study at El-Dwaim Teaching Hospital in Sudan analyzed 512 cases of mini-laparotomy cholecystectomy performed over 11 years, focusing on operative duration, complications, and length of hospital stay.
- Results showed that the procedure is safe, with most operations lasting under 60 minutes, low complication rates, and an average postoperative hospital stay of just 24 hours, making it a suitable choice in areas with limited surgical resources.